Background
In 2020, the World Health Organization (WHO) launched the Global Strategy to Accelerate the Elimination of Cervical Cancer, committing to its worldwide eradication. As a milestone initiative in global public health, the strategy impacts the health and well-being of women all over the world. The year 2025 marks the 30th anniversary of the Beijing Fourth World Conference on Women, and the Global Summit of Women will convene in Beijing again. Prof. Qiao Youlin, Associate Editor-in-Chief of Cancer Biology & Medicine, dedicates to curating a special issue on Cervical Cancer Elimination. This special issue aims to promote academic dialogue and advance the establishment of a more equitable and accessible cervical cancer prevention and control system. It will systematically focus on health equity, unmet medical care, scientific advances, policy innovations, global efforts and strategies for accelerating cervical cancer elimination, particularly in low-resource settings.
We cordially invite scholars worldwide to contribute latest research findings and practical experiences to this special issue.
Guest Editor
Prof. Qiao Youlin
• Professor, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences / Peking Union Medical College
• Researcher, Epidemiology Research Office, Cancer Hospital, National Cancer Center / Chinese Academy of Medical Sciences
• Member, WHO Expert Group on Global Elimination of Cervical Cancer
• Expert, HPV Working Group of the WHO Strategic Advisory Group of Experts (SAGE)
• Expert Receiving Special Government Allowance from the State Council
• WHO/IARC Medal of Honor for Outstanding Contributions to Cancer Research (2011)
• Pearline Global Prize for Humanitarian Scientist in Cancer Research (2018)
• Total citations: 31503, H-index: 89
Scopes of the Special Issue
We invite submissions on the following themes:
• Global/China progress toward cervical cancer elimination
• Epidemiology and disease burden of cervical cancer
• HPV prophylactic vaccines and therapeutic vaccines
• Novel technologies for cervical cancer screening
• Therapeutic innovations for HPV infection or cervical lesions
• Prevention and control of cervical cancer in low resource areas
• Digital/Intelligent/AI technologies assisted medical staff training and population management for cervical cancer prevention
Manuscript Types
We welcome submissions of high-quality Editorials, Perspectives, Reviews, and Original Articles (Please indicate “Special Issue on Cervical Cancer Elimination” in the title page of your manuscript)
Manuscript Format:
Editorial
Editorials are comprised of commentary and analysis on the leading-edge discoveries in cancer research and significant advances in cancer diagnosis and treatment.
• 2,500 words of text
• 20 references in maximum
• 3 figures and/or tables in maximum
Perspective
Perspectives focus on timely and significant topics in specific field and discuss future directions based on the current advances, sometimes with personal insights.
• 2,500 words of text
• 20 references in maximum
• 3 figures and/or tables in maximum
Review
Reviews discuss recent progress on topics of broad interest to cancer researchers or cancer care professionals. Solicited reviews will also be sent out for peer review.
• 250-word abstract
• 7,000 words of text
• 75 references or more
• 7 figures and/or tables in maximum
Original Article
Original Articles report significant new findings or important clinical experience in cancer area, which have valuable implications.
• 300-word abstract
• 6,000 words of text
• 50 references or more
• 8 figures and/or tables in maximum
• Results and Discussion must not be combined
• Additional display items may be published as supplementary information
Please find more details about manuscript preparation in Instructions for Authors.
Important Dates
• Submission Deadline: [2025.7.15]
• Expected Publication: [2025.9.30]
For inquiries, please contact:
Dr. Wang Yihan, Scientific Editor
Email: [email protected]